Rocky Mountain Leukemia, Lymphoma & Myeloma Summit - Precision. Progress. Practice.
Accreditation: 9.00 ACPE Pharmacy | 9.00 AMA PRA Category 1 Credit™ | 9.00 ABIM MOC II | 9.00 Nursing Contact Hours
Venue: Hyatt Regency Salt Lake City, 170 South West Temple Street, Salt Lake City, UT, United States
Official conference page for Rocky Mountain Leukemia, Lymphoma & Myeloma Summit - Precision. Progress. Practice.. https://binaytara.org/projects/conferences/rocky-mountain-leukemia-lymphoma-myeloma-summit-precision-progress-practice
About Rocky Mountain Leukemia, Lymphoma & Myeloma Summit - Precision. Progress. Practice.


Faculty and committee
Our Speakers
Planning Committee
Faculty
Conference program and agenda
Agenda
Day 1: Friday, September 18th, 2026
All timings are in Mountain Time (MDT, GMT-06:00) time.
01:05 PM - 01:20 PM
How I Treat Acute Myeloid Leukemia in 2026
01:20 PM - 01:35 PM
How I Treat Acute Lymphoblastic Leukemia in 2026 – Adam Duvall, MD
01:35 PM - 01:45 PM
Q&A and Discussion
01:45 PM - 01:55 PM
Case Presentation: The Gray Zone – Controversy and Clinical Judgement in Acute Leukemia
01:55 PM - 02:35 PM
Case Discussion: The Gray Zone – Controversy and Clinical Judgement in Acute Leukemia
Panelists:
Adam Duvall, MD; Zaker Schwabkey, MD
Session Chair: Daniel Arthur Ermann, MD
02:50 PM - 03:05 PM
Evolving Treatment Landscape in Newly Diagnosed Large B-Cell Lymphoma
03:05 PM - 03:20 PM
How I Treat R/R LBCL in 2026 – Richard T. Maziarz, MD
03:20 PM - 03:50 PM
Panel Discussion: Practical Decision-Making in Community Practice
03:50 PM - 04:00 PM
Case Presentation: The Gray Zone – Controversy and Clinical Judgement in Acute Leukemia
04:00 PM - 04:20 PM
Case Discussion: The Gray Zone – Controversy and Clinical Judgement in Acute Leukemia
Moderators:
Daniel Arthur Ermann, MD
Panelists:
Richard T. Maziarz, MD
Day 2: Saturday, September 19th, 2026
Session Chair: Xylina Gregg, MD
08:25 AM - 08:40 AM
How I Treat Indolent Lymphoma in 2026 – Narendranath Epperla, MD
08:40 AM - 08:55 AM
How I Treat Chronic Lymphocytic Leukemia (CLL) in 2026 – Daniel Arthur Ermann, MD
08:55 AM - 09:05 AM
Q&A and Discussion – Narendranath Epperla, MD; Daniel Arthur Ermann, MD
09:05 AM - 09:15 AM
Case Presentation: The Gray Zone – Controversy and Clinical Judgement in Low-grade Lymphoma & CLL
09:15 AM - 09:55 AM
Case Discussion: The Gray Zone – Controversy and Clinical Judgement in Low-grade Lymphoma & CLL
Moderators:
Xylina Gregg, MD
Panelists:
Narendranath Epperla, MD; Daniel Arthur Ermann, MD
Session Chair: Christopher Cahoon, PharmD
Venue and map
Accreditations and continuing education
Acknowledgement of Commercial Support
This activity is supported with an Independent Medical Education grant from Pfizer.
